avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Msx2 | mm10_v2_chr13_-_53473074_53473074 | 0.40 | 1.7e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_-_79285502 Show fit | 10.45 |
ENSMUST00000165408.1
|
BAI1-associated protein 2-like 2 |
|
chr15_-_79285470 Show fit | 7.47 |
ENSMUST00000170955.1
|
BAI1-associated protein 2-like 2 |
|
chr15_-_36879816 Show fit | 5.60 |
ENSMUST00000100713.2
|
predicted gene 10384 |
|
chr2_+_4017727 Show fit | 4.90 |
ENSMUST00000177457.1
|
FERM domain containing 4A |
|
chrX_+_21484532 Show fit | 4.69 |
ENSMUST00000089188.2
|
angiotensin II receptor, type 2 |
|
chr6_-_36811361 Show fit | 4.19 |
ENSMUST00000101534.1
|
pleiotrophin |
|
chr1_-_132390301 Show fit | 4.18 |
ENSMUST00000132435.1
|
transmembrane and coiled-coil domains 2 |
|
chr11_+_95010277 Show fit | 3.61 |
ENSMUST00000124735.1
|
sterile alpha motif domain containing 14 |
|
chr11_+_67171095 Show fit | 2.83 |
ENSMUST00000018641.7
|
myosin, heavy polypeptide 2, skeletal muscle, adult |
|
chr3_+_40800778 Show fit | 2.74 |
ENSMUST00000169566.1
|
polo-like kinase 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 17.9 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.4 | 5.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 4.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.2 | 4.7 | GO:0035566 | regulation of metanephros size(GO:0035566) |
1.0 | 4.2 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.1 | 4.0 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.4 | 2.7 | GO:0098535 | positive regulation of centriole replication(GO:0046601) de novo centriole assembly(GO:0098535) |
0.0 | 2.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.4 | 2.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.5 | 2.1 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 17.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.7 | 5.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 4.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 4.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.5 | 2.7 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 2.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 2.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 1.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.4 | 1.6 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 1.6 | GO:0000786 | nucleosome(GO:0000786) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 15.2 | GO:0005543 | phospholipid binding(GO:0005543) |
0.0 | 4.9 | GO:0030674 | protein binding, bridging(GO:0030674) |
1.2 | 4.7 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
1.4 | 4.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.0 | 4.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 3.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 2.5 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 2.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 1.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 1.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 4.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 3.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 2.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 1.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 1.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 6.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 2.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 2.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 2.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 1.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 1.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |